Physician profile
David Cameron
NPI 1801987615
$6,677.38
in general payments reported to CMS, 2019-2025
22 companies · $1,850 in 2025
The $1,850 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $137 · 2021: $486 · 2022: $1,065 · 2023: $859 · 2024: $1,689 · 2025: $1,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,397.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,326.24 | 2019-2025 | |
| Inspire Medical Systems, INC. | $1,092.51 | 2022-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,037.48 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $866.78 | 2019-2025 | Dupixent |
| Optinose US, INC. | $638.80 | 2019-2025 | |
| Medtronic, INC. | $394.93 | 2022-2025 | Propel, Nuvent, Pteye Parathyroid Detection System |
| Intersect Ent, INC. | $326.16 | 2019-2021 | |
| Stryker Corporation | $256.83 | 2019-2025 | Xpress Loprofile |
| Cochlear Americas | $167.24 | 2024-2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Takeda Pharmaceuticals U.S.A., INC. | $103.60 | 2021-2025 | Cuvitru, Hyqvia |
| Alk-Abello, INC | $93.61 | 2019-2022 | |
| Aerin Medical INC. | $67.61 | 2022-2025 | |
| Watermark Medical, INC. | $49.68 | 2024 | |
| Amgen INC. | $46.38 | 2025 | Tezspire |
| Shire North American Group INC | $46.11 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $33.48 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Smith+Nephew, INC. | $33.00 | 2019 | |
| Acclarent, INC | $32.81 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $24.69 | 2023 | |
| Paratek Pharmaceuticals, INC. | $14.37 | 2025 | Xhance |
| Medtronic USA, INC. | $12.85 | 2019 | |
| Kaleo, INC. | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cameron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.